Eli Lilly and Company（LLY）— 图表、结构与Closelook解读

关于Eli Lilly and Company

Eli Lilly and Company（LLY）在美国交易所交易，行业分类为Healthcare。该股为HALO Growth 100的成分股。

Closelook公司评分综合为66/100（动量70、质量92、估值37），基于7个模块 — 完整的三层拆解、图表结构与历史类比在上方实时加载。

财报记录

在覆盖的10次财报中，EPS超预期9次、营收超预期8次；财报后三日反应为上涨4次 · 持平3次 · 下跌3次（截至2026-08-03的卡片）。 The calmest record in the series — and that is the finding. While the AI names swing ±15 to ±30 on their prints, Eli Lilly's entire ten-print distribution fits inside ±7.4%: nine EPS beats, a 4-3-3 reaction count, nothing violent in either direction. This is what a mega-cap looks like when the market believes the demand story and only argues about pace — the GLP-1 franchise as the anti-AI trade, repricing in single digits while the technology complex reprices in tens. It prints Wednesday morning at 1,125 — 9.9% off its high, above its 200-day — the same morning as Novo Nordisk: a head-to-head print in the one duopoly the tape trusts more than compute.

Eli Lilly and Company完整财报记录卡 →

closelook.net是一份投资研究日记 — 市场结构、指数成分与评分均为我们自己的解读，不构成投资建议。 相关页面： LLY新闻流 · 指数对比 · 行业离散度 · 扫描器.